| abstract |
Kind Code: A1 Provided are peptides that inhibit the enzyme activity of tyrosinase, as well as formulations and methods for their use in reducing skin pigmentation, and methods of administering inhibitory peptides in topical formulations. The peptides have an IC50 of tyrosinase of less than 10 mM, and the peptides are further characterized by the sequence RADRADC and PLG-OH.δΊ¦, skin treatment methods further include the use of peptides characterized by the amino acid sequence SFLLRN. [Selection figure] None |